Filing Details

Accession Number:
0001641172-25-010912
Form Type:
13G Filing
Publication Date:
2025-05-14 20:00:00
Filed By:
Harvey Partners
Company:
Harvard Bioscience Inc (NASDAQ:HBIO)
Filing Date:
2025-05-15
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
HARVEY PARTNERS, LLC 0 2,187,500 4.96%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  See Item 2 for additional information.


SCHEDULE 13G


 
HARVEY PARTNERS, LLC
 
Signature:/s/ Jeffrey C. Moskowitz
Name/Title:Jeffrey C. Moskowitz, Managing Member
Date:05/15/2025